EMA Committee Gives Green Light to Alcohol Abuse Drug – Medscape

EMA Committee Gives Green Light to Alcohol Abuse Drug – Medscape
Filed under: Alcohol Abuse


Medscape

EMA Committee Gives Green Light to Alcohol Abuse Drug
Medscape
An advisory committee to the European Medicines Agency (EMA) has recommended that nalmefene ( Selincro, H. Lundbeck A/S), a drug for the reduction of alcohol consumption in adult patients with alcohol dependencies who have a high drinking risk level,
Lundbeck's alcohol dependency drug wins EU green lightReuters
Biotie: Selincro(TM) (nalmefene) Receives Positive Opinion for Approval in the MarketWatch (press release)

all 27 news articles »

Source

 

Related Alcohol Abuse Information…